Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 9, 2007, Pages 946-952

  Majid, Dewan S A ^a,c   Kopkan, Libor ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Hypertension; Nitric oxide; Salt sensitivity; Superoxide anion

Indexed keywords

APOCYNIN; ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SUPEROXIDE; TEMPOL;

BLOOD PRESSURE; CHEMICAL INTERACTION; DRUG INHIBITION; HYPERTENSION; KIDNEY BLOOD FLOW; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; SODIUM RETENTION;

ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOGS; ENZYME INHIBITORS; HYPERTENSION; KIDNEY; MICE; NATRIURESIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; RATS; SODIUM CHLORIDE; SUPEROXIDES;

EID: 34447506226     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04642.x     Document Type: Review

References (79)

1. Kone BC. Nitric oxide synthesis in the kidney: Isoforms, biosynthesis, and functions in health. Semin. Nephrol. 2004 24 : 299 315.
2. Majid DS, Navar LG. Nitric oxide in the control of renal hemodynamics and excretory function. Am. J. Hypertens. 2001 14 (Suppl S74 82.
3. Herrera M, Garvin JL. Recent advances in the regulation of nitric oxide in the kidney. Hypertension 2005 45 : 1062 7.
4. Wilcox CS. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol. Scand. 2003 179 : 217 23.
5. Grisham MB, Jourd'Heuil D, Wink DA. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation. Am. J. Physiol. 1999 276 : G315 21.
6. Wink DA, Mitchell JB. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 1998 25 : 434 56.
7. Wink DA, Miranda KM, Espey MG et al. Mechanisms of the antioxidant effects of nitric oxide. Antioxid. Redox Signal. 2001 3 : 203 13.
8. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension? Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005 289 : R913 35.
9. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ. Res. 2000 87 : 840 4.
10. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. 1986 250 : H822 7.
11. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: Molecular and cellular mechanisms. Hypertension 2003 42 : 1075 81.
12. Wolin MS, Ahmad M, Gupte SA. The sources of oxidative stress in the vessel wall. Kidney Int. 2005 67 : 1659 61.
13. Araujo M, Welch WJ. Oxidative stress and nitric oxide in kidney function. Curr. Opin. Nephrol. Hypertens. 2006 15 : 72 7.
14. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J. Physiol. Pharmacol. 2003 54 : 469 87.
15. Majid DS, Nishiyama A. Nitric oxide blockade enhances renal reponses to superoxide dismutase inhibition in dogs. Hypertension 2002 39 : 293 7.
16. Majid DSA, Nishiyama A, Jackson KE, Castillo A. Inhibition of nitric oxide synthase enhances superoxide activity in canine kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004 287 : R27 32.
17. Majid DS, Nishiyama A, Jackson KE, Castillo A. Superoxide scavenging attenuates renal responses to ANG II during nitric oxide synthase inhibition in anesthetized dogs. Am. J. Physiol. Renal Physiol. 2005 288 : F412 19.
18. Huie RE, Padmaja S. The reaction of NO with superoxide. Free Radic. Res. Commun. 1993 18 : 195 9.
19. Modlinger PS, Wilcox CS, Aslam S. Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin. Nephrol. 2004 24 : 354 65.
20. Zou AP, Cowley Jr. AW. Production and actions of superoxide in the renal medulla. Hypertension 2001 37 : 547 53.
21. Makino A, Skelton MM, Zou AP, Roman RJ, Cowley Jr. AW. Increased renal medullary oxidative stress produces hypertension. Hypertension 2002 39 : 667 72.
22. Lopez B, Salom MG, Arregui B, Valero F, Fenoy FJ. Role of superoxide in modulating the renal effects of angiotensin II. Hypertension 2003 42 : 1150 6.
23. Haque MZ, Majid DS. Assessment of renal functional phenotype in mice lacking gp91phox subunit of NAD(P)H oxidase. Hypertension 2004 43 : 335 40.
24. Kopkan L, Majid DS. Superoxide contributes to development of salt sensitivity and hypertension induced by nitric oxide deficiency. Hypertension 2005 46 : 1026 31.
25. Kopkan L, Majid DS. Enhanced superoxide activity modulates renal function in NO-deficient hypertensive rats. Hypertension 2006 47 : 568 72.
26. Kopkan L, Castillo A, Navar LG, Majid DS. Enhanced superoxide generation modulates renal function in angiotensin II-induced hypertensive rats. Am. J. Physiol. Renal Physiol. 2006 290 : F80 6.
27. Patterson ME, Mouton CR, Mullins JJ, Mitchell KD. Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertension. Am. J. Physiol. Renal Physiol. 2005 289 : F754 9.
28. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: Role of nitric oxide. Hypertension 1998 32 : 59 64.
29. Tian N, Thrasher KD, Gundy PD, Hughson MD, Manning Jr. RD. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension 2005 45 : 934 9.
30. Rodriguez-Iturbe B, Sato T, Quiroz Y, Vaziri ND. AT-1 receptor blockade prevents proteinuria, renal failure, hyperlipidemia, and glomerulosclerosis in the Imai rat. Kidney Int. 2004 66 : 668 75.
31. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Hypertension 1997 95 : 588 93.
32. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: All for one and one for all. Am. J. Physiol. Renal Physiol. 2004 286 : F606 16.
33. Manning RD, Meng S, Tian N. Renal and vascular oxidative stress and salt sensitivity of arterial pressure. Acta Physiol. Scand. 2003 179 : 243 50.
34. Ortiz PA, Garvin JL. Superoxide stimulates NaCl absorption by the thick ascending limb. Am. J. Physiol. Renal Physiol. 2002 283 : F957 62.
35. Mori T, Cowley Jr. AW. Renal oxidative stress in medullary thick ascending limbs produced by elevated NaCl and glucose. Hypertension 2004 43 : 341 6.
36. Mikkelsen RB, Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation induced signal transduction mechanisms. Oncogene 2003 22 : 5734 54.
37. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 1991 288 : 481 7.
38. Salgo MG, Stone K, Squadrito GL, Battista JR, Pryor WA. Peroxynitrite causes DNA nicks in plasmid pBR322. Biochem. Biophys. Res. Commun. 1995 210 : 1025 30.
39. Liu S, Beckman JS, Ku DD. Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs. J. Pharmacol. Exp. Ther. 1994 268 : 1114 21.
40. Nossaman BD, Dabisch PA, Liles JT et al. Peroxynitrite does not impair pulmonary and systemic vascular responses. J. Appl. Physiol. 2004 96 : 455 62.
41. Lefer DJ, Scalia R, Campbell B et al. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J. Clin. Invest. 1997 99 : 684 91.
42. Reckelhoff JF, Romero JC. Role of oxidative stress in angiotensin-induced hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003 284 : R893 912.
43. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signalling in hypertension. What is the clinical significance? Hypertension 2004 44 : 248 52.
44. Schnackenberg CG, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of I-iso prostaglandin F2α. Hypertension 1999 33 : 424 8.
45. Park JB, Touyz RM, Chen X, Schiffrin EL. Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am. J. Hypertens. 2002 15 : 78 84.
46. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 2001 37 : 781 6.
47. Taylor NE, Glocka P, Liang M, Cowley Jr. AW. NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension 2006 47 : 692 8.
48. Laffer CL, Bolterman RJ, Romero JC, Elijovich F. Effect of salt on isoprostanes in salt-sensitive essential hypertension. Hypertension 2006 47 : 434 40.
49. Zhou MS, Jaimes EA, Raij L. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: Role of eNOS and oxidant stress. Hypertension 2004 44 : 186 90.
50. Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS. A mouse model of angiotensin II slow pressor response: Role of oxidative stress. J. Am. Soc. Nephrol. 2002 13 : 2860 8.
51. Welch WJ, Blau J, Xie H, Chabrashvili T, Wilcox CS. Angiotensin-induced defects in renal oxygenation: Role of oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 2005 288 : H22 8.
52. Howard LL, Patterson ME, Mullins JJ, Mitchell KD. Salt-sensitive hypertension develops after transient induction of ANG II-dependent hypertension in Cyp1a1-Ren2 transgenic rats. Am. J. Physiol. Renal Physiol. 2005 288 : F810 15.
53. Manning Jr. RD, Tian N, Meng S. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am. J. Nephrol. 2005 25 : 311 17.
54. Patel A, Layne S, Watts D, Kirchner KA. l-Arginine administration normalizes pressure natriuresis in hypertensive Dahl rats. Hypertension 1993 22 : 863 9.
55. Hu L, Manning Jr. RD. Role of nitric oxide in regulation of long-term pressure-natriuresis relationship in Dahl rats. Am. J. Physiol. 1995 268 : H2375 83.
56. Beswick RA, Dorrance AM, Leite R, Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 2001 38 : 1107 11.
57. Li JS, Sventek P, Schiffrin EL. Effect of antihypertensive treatment and Nω-nitro-l-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats. J. Hypertens. 1996 14 : 1331 9.
58. Fenning A, Harrison G, Rose'meyer R, Hoey A, Brown L. l-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 2005 289 : H1408 16.
59. Yanes L, Romero D, Iliescu R et al. Systemic arterial pressure response to two weeks of tempol therapy in SHR. Involvement of NO, the RAS, and oxidative stress. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005 288 : R903 8.
60. Welch WJ, Mendonca M, Blau J et al. Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat. Kidney Int. 2005 68 : 179 87.
61. de Richelieu LT, Sorensen CM, Holstein-Rathlou NH, Salomonsson M. NO-independent mechanism mediates tempol-induced renal vasodilation in SHR. Am. J. Physiol. Renal Physiol. 2005 289 : F1227 34.
62. Brannstrom K, Morsing P, Arendshorst WJ. Candesartan normalizes exaggerated tubuloglomerular feedback activity in young spontaneously hypertensive rats. J. Am. Soc. Nephrol. 1999 11 (S uppl S213 19.
63. Welch WJ, Tojo A, Wilcox CS. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am. J. Physiol. Renal Physiol. 2000 278 : F769 76.
64. Beierwaltes WH, Arendshorst WJ, Klemmer PJ. Electrolyte and water balance in young spontaneously hypertensive rats. Hypertension 1982 4 : 908 15.
65. Chabrashvili T, Kitiyakara C, Blau J et al. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003 285 : R117 24.
66. Haque MZ, Nomanbhoy F, Castillo A, Majid DS. High salt intake causes delayed and attenuated hypertensive response to chronic angiotensin II administration in mice lacking gp91phox subunit of NAD(P)H oxidase. FASEB J. 2004 18 : A1038 (Abstract).
67. Chin SY, Wang CT, Majid DS, Navar LG. Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat. Am. J. Physiol. 1998 274 : F876 82.
68. Vaneckova I, Kramer HJ, Novotna J et al. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats. Kidney Blood Pressure Res. 2005 28 : 117 26.
69. Kopkan L, Thumova M, Huskova Z, Vanourkova Z, Cervenka L, Majid DS. Enhanced superoxide activity and its interaction with nitric oxide modulate renal function in pre-hypertensive Ren-2 transgenic rats. Hypertension 2006 : 48 : E59 (Abstract).
70. Tolins JP, Shultz PJ. Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int. 1994 46 : 230 6.
71. Usui M, Egashira K, Kitamoto S et al. Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats. Hypertension 1999 34 : 546 51.
72. Cosentino F, Barker JE, Brand MP et al. Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2001 21 : 496 502.
73. Guzik TJ, West NE, Pillai R, Taggart DP, Channon KM. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension 2002 39 : 1088 94.
74. Adeagbo AS, Joshua IG, Falkner C, Matheson PJ. Tempol, an antioxidant, restores endothelium-derived hyperpolarizing factor-mediated vasodilation during hypertension. Eur. J. Pharmacol. 2003 481 : 91 100.
75. Cuzzocrea S, Mazzon E, Dugo L, Di Paola R, Caputi AP, Salvemini D. Superoxide: A key player in hypertension. FASEB J. 2004 18 : 94 101.
76. Vaziri ND, Ni Z, Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 1998 31 : 1248 54.
77. Welch WJ, Tojo A, Lee JU, Kang DG, Schnackenberg CG, Wilcox CS. Nitric oxide synthase in the JGA of the SHR. Expression and role in tubuloglomerular feedback. Am. J. Physiol. 1999 277 : F130 8.
78. Csiszar A, Ungvari Z, Edwards JG et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ. Res. 2002 90 : 1159 66.
79. Husain K, Hazelrigg SR. Oxidative injury due to chronic nitric oxide synthase inhibition in rat: Effect of regular exercise on the heart. Biochim. Biophys. Acta 2002 1587 : 75 82.